Literature DB >> 19032728

Predictive factors for generalized seizures after deliberate citalopram overdose.

W Stephen Waring1, Julie A Gray, Ann Graham.   

Abstract

AIMS: Seizures are a recognized complication of citalopram overdose. The present study sought to establish risk factors for seizures in this high-risk patient group, including stated dose ingested, co-ingested drugs or ethanol, and electrolyte disturbances.
METHODS: A retrospective casenote review was carried out of patients who attended the Emergency Department due to citalopram overdose between January 2000 and July 2007 inclusive. Stepwise logistic regression analysis considered age, gender, stated citalopram dose, acute ethanol consumption, co-ingested drugs, administration of activated charcoal, and hyponatraemia.
RESULTS: There were 241 patients (177 women), and the median (interquartile range) stated citalopram dose was 300 mg (200 to 600 mg). Generalized seizures occurred in 18 patients (7.5%). Logistic regression analysis found co-ingested tricyclic antidepressants or venlafaxine predicted seizures with odds ratio = 15 (95% confidence interval 3, 75). In the absence of co-ingested drugs, the minimum citalopram dose associated with seizures was 400 mg. Odds ratio for seizures = 1.1 (95% confidence interval 1.0, 1.2) for every 100 mg increment in citalopram dose. Seizures were associated with a greater need for invasive ventilatory support, higher creatine kinase activity, and prolonged hospital stay.
CONCLUSIONS: Generalized seizures are an important manifestation of citalopram toxicity, and cannot be explained solely by electrolyte disturbances or co-ingestion of other drugs or ethanol. The strongest predictors of seizures in this patient series were ingestion of high citalopram dosages and co-ingestion of drugs capable of lowering seizure threshold.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19032728      PMCID: PMC2675776          DOI: 10.1111/j.1365-2125.2008.03294.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  26 in total

1.  Hyponatremia associated with escitalopram.

Authors:  Jill A Covyeou; Cherry W Jackson
Journal:  N Engl J Med       Date:  2007-01-04       Impact factor: 91.245

2.  Symptoms and signs of severe citalopram overdose.

Authors:  L Grundemar; B Wohlfart; C Lagerstedt; F Bengtsson; G Eklundh
Journal:  Lancet       Date:  1997-05-31       Impact factor: 79.321

3.  Citalopram overdose--review of cases treated in Swedish hospitals.

Authors:  M Personne; G Sjöberg; H Persson
Journal:  J Toxicol Clin Toxicol       Date:  1997

Review 4.  Citalopram. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness.

Authors:  R J Milne; K L Goa
Journal:  Drugs       Date:  1991-03       Impact factor: 9.546

5.  Inhibition of serotonin transporters by cocaine and meprylcaine through 5-TH2C receptor stimulation facilitates their seizure activities.

Authors:  Katsuya Morita; Masahiro Hamamoto; Shigeaki Arai; Shigeo Kitayama; Masahiro Irifune; Michio Kawahara; Kenji Kihira; Toshihiro Dohi
Journal:  Brain Res       Date:  2005-09-28       Impact factor: 3.252

Review 6.  Depression in epilepsy: phenomenology, diagnosis and management.

Authors:  R Seethalakshmi; Ennapadam S Krishnamoorthy
Journal:  Epileptic Disord       Date:  2007-02-15       Impact factor: 1.819

Review 7.  Escitalopram: a review of its use in the management of major depressive disorder.

Authors:  David Murdoch; Susan J Keam
Journal:  Drugs       Date:  2005       Impact factor: 9.546

8.  Seizures and myoclonus associated with antidepressant treatment: assessment of potential risk factors, including CYP2D6 and CYP2C19 polymorphisms, and treatment with CYP2D6 inhibitors.

Authors:  O Spigset; K Hedenmalm; M L Dahl; B E Wiholm; R Dahlqvist
Journal:  Acta Psychiatr Scand       Date:  1997-11       Impact factor: 6.392

9.  Clinical course and toxicokinetic data following isolated citalopram overdose in an infant.

Authors:  Lawrence N Masullo; Michael A Miller; S David Baker; Sudip Bose; Marc Levsky
Journal:  Clin Toxicol (Phila)       Date:  2006       Impact factor: 4.467

10.  The anticonvulsant effect of citalopram on El mice, and the levels of tryptophan and tyrosine and their metabolites in the brain.

Authors:  H Kabuto; I Yokoi; M Takei; T Kurimoto; A Mori
Journal:  Neurochem Res       Date:  1994-04       Impact factor: 3.996

View more
  6 in total

1.  Evaluation of a QT nomogram for risk assessment after antidepressant overdose.

Authors:  W Stephen Waring; Ann Graham; Julie Gray; Allen D Wilson; Catherine Howell; D Nicholas Bateman
Journal:  Br J Clin Pharmacol       Date:  2010-12       Impact factor: 4.335

2.  Neonatal Toxicity From Escitalopram Use In Utero: A Case Report.

Authors:  Jessica Degiacomo; Sherry Luedtke
Journal:  J Pediatr Pharmacol Ther       Date:  2016 Nov-Dec

3.  Seizures during antidepressant treatment in psychiatric inpatients--results from the transnational pharmacovigilance project "Arzneimittelsicherheit in der Psychiatrie" (AMSP) 1993-2008.

Authors:  M Köster; R Grohmann; R R Engel; M A Nitsche; E Rüther; D Degner
Journal:  Psychopharmacology (Berl)       Date:  2013-09-26       Impact factor: 4.530

4.  Clinical use of antidepressant therapy and associated cardiovascular risk.

Authors:  W Stephen Waring
Journal:  Drug Healthc Patient Saf       Date:  2012-08-17

5.  Massive Citalopram Overdose Associated with Recurrent Seizures and Bilateral Shoulder Dislocations.

Authors:  Shafeajafar Zoofaghari; Anselm Wong; Pegah Kiarasi; Farzad Gheshlaghi
Journal:  J Res Pharm Pract       Date:  2020-10-08

6.  Treatment of acute and remote symptomatic seizures.

Authors:  Barbara S Koppel
Journal:  Curr Treat Options Neurol       Date:  2009-07       Impact factor: 3.972

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.